US20040001889A1
(en)
|
2002-06-25 |
2004-01-01 |
Guohua Chen |
Short duration depot formulations
|
DK1539101T3
(da)
|
2002-07-31 |
2009-04-27 |
Alza Corp |
Injicerbare, multi-modale polymere depotsammens tninger og anvendelser deraf
|
US7731947B2
(en)
|
2003-11-17 |
2010-06-08 |
Intarcia Therapeutics, Inc. |
Composition and dosage form comprising an interferon particle formulation and suspending vehicle
|
US20070184084A1
(en)
*
|
2003-05-30 |
2007-08-09 |
Guohua Chen |
Implantable elastomeric caprolactone depot compositions and uses thereof
|
US8980300B2
(en)
|
2004-08-05 |
2015-03-17 |
Advanced Cardiovascular Systems, Inc. |
Plasticizers for coating compositions
|
US7981065B2
(en)
*
|
2004-12-20 |
2011-07-19 |
Cardiac Pacemakers, Inc. |
Lead electrode incorporating extracellular matrix
|
US8060219B2
(en)
|
2004-12-20 |
2011-11-15 |
Cardiac Pacemakers, Inc. |
Epicardial patch including isolated extracellular matrix with pacing electrodes
|
US20060142234A1
(en)
*
|
2004-12-23 |
2006-06-29 |
Guohua Chen |
Injectable non-aqueous suspension
|
WO2006083761A2
(en)
|
2005-02-03 |
2006-08-10 |
Alza Corporation |
Solvent/polymer solutions as suspension vehicles
|
US11246913B2
(en)
|
2005-02-03 |
2022-02-15 |
Intarcia Therapeutics, Inc. |
Suspension formulation comprising an insulinotropic peptide
|
US7252834B2
(en)
|
2005-04-25 |
2007-08-07 |
Clemson University Research Foundation (Curf) |
Elastin stabilization of connective tissue
|
US20070043416A1
(en)
*
|
2005-08-19 |
2007-02-22 |
Cardiac Pacemakers, Inc. |
Implantable electrode array
|
US8852638B2
(en)
|
2005-09-30 |
2014-10-07 |
Durect Corporation |
Sustained release small molecule drug formulation
|
US20070184087A1
(en)
*
|
2006-02-06 |
2007-08-09 |
Bioform Medical, Inc. |
Polysaccharide compositions for use in tissue augmentation
|
US20070253994A1
(en)
*
|
2006-04-28 |
2007-11-01 |
Medtronic, Inc. |
Intraspinal Drug Delivery Methods and Devices To Alleviate Chronic Pelvic Pain
|
DK2020990T3
(da)
|
2006-05-30 |
2010-12-13 |
Intarcia Therapeutics Inc |
Strømningsmodulator med en indre kanal til et todelt osmotisk fremføringssystem
|
US9173773B2
(en)
*
|
2006-06-21 |
2015-11-03 |
Johnson & Johnson Vision Care, Inc. |
Punctal plugs for the delivery of active agents
|
EP2049081B1
(en)
|
2006-08-09 |
2012-11-14 |
Intarcia Therapeutics, Inc. |
Osmotic delivery systems and piston assemblies
|
US8529951B1
(en)
|
2007-02-21 |
2013-09-10 |
Anand Ramamurthi |
Elastogenic cues and methods for using same
|
CN101715340A
(zh)
|
2007-04-23 |
2010-05-26 |
精达制药公司 |
促胰岛素释放肽的混悬制剂及其应用
|
ES2562878T3
(es)
|
2007-05-25 |
2016-03-08 |
Indivior Uk Limited |
Formulaciones de liberación sostenida de compuestos de risperidona
|
US20090004243A1
(en)
|
2007-06-29 |
2009-01-01 |
Pacetti Stephen D |
Biodegradable triblock copolymers for implantable devices
|
US20090306120A1
(en)
*
|
2007-10-23 |
2009-12-10 |
Florencia Lim |
Terpolymers containing lactide and glycolide
|
US20090104241A1
(en)
*
|
2007-10-23 |
2009-04-23 |
Pacetti Stephen D |
Random amorphous terpolymer containing lactide and glycolide
|
US8661630B2
(en)
|
2008-05-21 |
2014-03-04 |
Abbott Cardiovascular Systems Inc. |
Coating comprising an amorphous primer layer and a semi-crystalline reservoir layer
|
US20090110713A1
(en)
*
|
2007-10-31 |
2009-04-30 |
Florencia Lim |
Biodegradable polymeric materials providing controlled release of hydrophobic drugs from implantable devices
|
WO2009064806A1
(en)
*
|
2007-11-12 |
2009-05-22 |
Endologix, Inc. |
Method and agent for in-situ stabilization of vascular tissue
|
EP2219620B1
(en)
*
|
2007-11-13 |
2017-07-19 |
Surmodics, Inc. |
Viscous terpolymers as drug delivery platform
|
WO2009102467A2
(en)
|
2008-02-13 |
2009-08-20 |
Intarcia Therapeutics, Inc. |
Devices, formulations, and methods for delivery of multiple beneficial agents
|
WO2009105265A2
(en)
*
|
2008-02-21 |
2009-08-27 |
Vatrix Medical, Inc. |
Treatment of aneurysm with application of connective tissue stabilization agent in combination with a delivery vehicle
|
US8557273B2
(en)
*
|
2008-04-18 |
2013-10-15 |
Medtronic, Inc. |
Medical devices and methods including polymers having biologically active agents therein
|
US20090263443A1
(en)
*
|
2008-04-18 |
2009-10-22 |
Warsaw Orthopedics, Inc. |
Methods for treating post-operative effects such as spasticity and shivering with clondine
|
US8420114B2
(en)
*
|
2008-04-18 |
2013-04-16 |
Warsaw Orthopedic, Inc. |
Alpha and beta adrenergic receptor agonists for treatment of pain and / or inflammation
|
USRE48948E1
(en)
|
2008-04-18 |
2022-03-01 |
Warsaw Orthopedic, Inc. |
Clonidine compounds in a biodegradable polymer
|
US8475823B2
(en)
*
|
2008-04-18 |
2013-07-02 |
Medtronic, Inc. |
Baclofen formulation in a polyorthoester carrier
|
US8629172B2
(en)
*
|
2008-04-18 |
2014-01-14 |
Warsaw Orthopedic, Inc. |
Methods and compositions for treating post-operative pain comprising clonidine
|
US8956642B2
(en)
*
|
2008-04-18 |
2015-02-17 |
Medtronic, Inc. |
Bupivacaine formulation in a polyorthoester carrier
|
US8697113B2
(en)
*
|
2008-05-21 |
2014-04-15 |
Abbott Cardiovascular Systems Inc. |
Coating comprising a terpolymer comprising caprolactone and glycolide
|
US20100016833A1
(en)
*
|
2008-07-15 |
2010-01-21 |
Ogle Matthew F |
Devices for the Treatment of Vascular Aneurysm
|
GB0819296D0
(en)
*
|
2008-10-21 |
2008-11-26 |
Smith & Nephew |
Coating II
|
US20100119605A1
(en)
*
|
2008-11-12 |
2010-05-13 |
Isenburg Jason C |
Compositions for tissue stabilization
|
US8951546B2
(en)
*
|
2008-12-23 |
2015-02-10 |
Surmodics Pharmaceuticals, Inc. |
Flexible implantable composites and implants comprising same
|
US8974808B2
(en)
*
|
2008-12-23 |
2015-03-10 |
Surmodics, Inc. |
Elastic implantable composites and implants comprising same
|
US9480643B2
(en)
|
2008-12-23 |
2016-11-01 |
Surmodics Pharmaceuticals, Inc. |
Implantable composites and implants comprising same
|
US9415197B2
(en)
*
|
2008-12-23 |
2016-08-16 |
Surmodics, Inc. |
Implantable suction cup composites and implants comprising same
|
US20100168807A1
(en)
*
|
2008-12-23 |
2010-07-01 |
Burton Kevin W |
Bioactive terpolymer compositions and methods of making and using same
|
US20100239632A1
(en)
|
2009-03-23 |
2010-09-23 |
Warsaw Orthopedic, Inc. |
Drug depots for treatment of pain and inflammation in sinus and nasal cavities or cardiac tissue
|
US20100261662A1
(en)
*
|
2009-04-09 |
2010-10-14 |
Endologix, Inc. |
Utilization of mural thrombus for local drug delivery into vascular tissue
|
US8697110B2
(en)
*
|
2009-05-14 |
2014-04-15 |
Abbott Cardiovascular Systems Inc. |
Polymers comprising amorphous terpolymers and semicrystalline blocks
|
JP5718925B2
(ja)
|
2009-09-28 |
2015-05-13 |
インターシア セラピューティクス,インコーポレイティド |
実質的な定常状態薬物送達の迅速な確立及び/又は停止
|
EP2485687A1
(en)
*
|
2009-10-09 |
2012-08-15 |
Vatrix Medical, Inc. |
In vivo chemical stabilization of vulnerable plaque
|
US8444624B2
(en)
*
|
2009-10-19 |
2013-05-21 |
Vatrix Medical, Inc. |
Vascular medical devices with sealing elements and procedures for the treatment of isolated vessel sections
|
US20110097375A1
(en)
*
|
2009-10-26 |
2011-04-28 |
Warsaw Orthopedic, Inc. |
Formulation for preventing or reducing bleeding at a surgical site
|
US20110097380A1
(en)
*
|
2009-10-28 |
2011-04-28 |
Warsaw Orthopedic, Inc. |
Clonidine formulations having antimicrobial properties
|
US9993441B2
(en)
|
2009-12-30 |
2018-06-12 |
Surmodics, Inc. |
Controlled release matrix barrier structure for subcutaneous medical devices
|
WO2012030822A1
(en)
|
2010-08-30 |
2012-03-08 |
Surmodics Pharmaceuticals, Inc. |
Process for reducing moisture in a biodegradable implant device
|
US9301946B2
(en)
|
2010-12-03 |
2016-04-05 |
Warsaw Orthopedic, Inc. |
Clonidine and GABA compounds in a biodegradable polymer carrier
|
US8623396B2
(en)
|
2010-12-03 |
2014-01-07 |
Warsaw Orthopedic, Inc. |
Compositions and methods for delivering clonidine and bupivacaine to a target tissue site
|
US8911468B2
(en)
|
2011-01-31 |
2014-12-16 |
Vatrix Medical, Inc. |
Devices, therapeutic compositions and corresponding percutaneous treatment methods for aortic dissection
|
US20120208755A1
(en)
|
2011-02-16 |
2012-08-16 |
Intarcia Therapeutics, Inc. |
Compositions, Devices and Methods of Use Thereof for the Treatment of Cancers
|
JP2014516695A
(ja)
|
2011-05-18 |
2014-07-17 |
バトリックス・メディカル・インコーポレイテッド |
血管安定化用被覆バルーン
|
CN102198080B
(zh)
*
|
2011-05-18 |
2012-12-05 |
山东省医疗器械研究所 |
一种治疗脑胶质瘤疾病的阿霉素缓释药棒及其制备方法
|
JP6339011B2
(ja)
*
|
2011-06-10 |
2018-06-06 |
ラムスコール インコーポレイテッド |
眼へのタンパク質の送出のための持続放出性製剤及びその調製方法
|
CN102274164B
(zh)
*
|
2011-08-22 |
2014-07-02 |
长春健欣生物医药科技开发有限公司 |
帕潘立酮及帕潘立酮衍生物的注射用缓释凝胶剂
|
AU2012328850B2
(en)
*
|
2011-10-24 |
2017-02-02 |
Braeburn Pharmaceuticals, Inc. |
Implantable drug delivery compositions and methods of treatment thereof
|
EP2782590A4
(en)
*
|
2011-11-23 |
2016-08-03 |
Durect Corp |
BIODEGRADABLE AND MEDIUM-RADIATED STERILIZED MEDICAMENTAL COMPOSITIONS
|
US9511018B2
(en)
|
2012-04-05 |
2016-12-06 |
Warsaw Orthopedic, Inc. |
Clonidine compounds in a biodegradable matrix
|
US9283241B2
(en)
|
2012-07-10 |
2016-03-15 |
Clemson University |
Treatment to render implants resistant to diabetes
|
US10245306B2
(en)
*
|
2012-11-16 |
2019-04-02 |
Isto Technologies Ii, Llc |
Flexible tissue matrix and methods for joint repair
|
US9066853B2
(en)
*
|
2013-01-15 |
2015-06-30 |
Warsaw Orthopedic, Inc. |
Clonidine compounds in a biodegradable fiber
|
RU2513838C1
(ru)
*
|
2013-02-21 |
2014-04-20 |
Общество с ограниченной ответственностью "ДЖИ-Групп" |
Гистоэквивалент-биопластический материал
|
US20140308352A1
(en)
|
2013-03-11 |
2014-10-16 |
Zogenix Inc. |
Compositions and methods involving polymer, solvent, and high viscosity liquid carrier material
|
AU2014249008B2
(en)
|
2013-03-11 |
2018-12-06 |
Durect Corporation |
Injectable controlled release composition comprising high viscosity liquid carrier
|
EP3079668A1
(en)
|
2013-12-09 |
2016-10-19 |
Durect Corporation |
Pharmaceutically active agent complexes, polymer complexes, and compositions and methods involving the same
|
KR20220138419A
(ko)
*
|
2014-04-21 |
2022-10-12 |
헤론 테라퓨틱스 인코포레이티드 |
장기간 작용하는 중합체 전달 시스템
|
US9801945B2
(en)
|
2014-04-21 |
2017-10-31 |
Heron Therapeutics, Inc. |
Long-acting polymeric delivery systems
|
WO2018048460A1
(en)
|
2014-04-21 |
2018-03-15 |
Heron Therapeutics, Inc. |
A pharmaceutical composition comprising a delivery system, an amide-type local anesthetic, and meloxicam
|
HUE052224T2
(hu)
|
2014-04-21 |
2021-04-28 |
Heron Therapeutics Inc |
Poliortoészterbõl és szerves sav segédanyagból álló készítmények
|
US9764122B2
(en)
|
2014-07-25 |
2017-09-19 |
Warsaw Orthopedic, Inc. |
Drug delivery device and methods having an occluding member
|
US9775978B2
(en)
|
2014-07-25 |
2017-10-03 |
Warsaw Orthopedic, Inc. |
Drug delivery device and methods having a retaining member
|
US9889085B1
(en)
|
2014-09-30 |
2018-02-13 |
Intarcia Therapeutics, Inc. |
Therapeutic methods for the treatment of diabetes and related conditions for patients with high baseline HbA1c
|
US10179191B2
(en)
|
2014-10-09 |
2019-01-15 |
Isto Technologies Ii, Llc |
Flexible tissue matrix and methods for joint repair
|
ES2808150T3
(es)
|
2014-11-07 |
2021-02-25 |
Indivior Uk Ltd |
Regímenes de dosificación de buprenorfina
|
WO2016196851A2
(en)
|
2015-06-03 |
2016-12-08 |
Intarcia Therapeutics, Inc. |
Implant placement and removal systems
|
US10076650B2
(en)
|
2015-11-23 |
2018-09-18 |
Warsaw Orthopedic, Inc. |
Enhanced stylet for drug depot injector
|
WO2017200943A1
(en)
|
2016-05-16 |
2017-11-23 |
Intarcia Therapeutics, Inc. |
Glucagon-receptor selective polypeptides and methods of use thereof
|
USD860451S1
(en)
|
2016-06-02 |
2019-09-17 |
Intarcia Therapeutics, Inc. |
Implant removal tool
|
USD840030S1
(en)
|
2016-06-02 |
2019-02-05 |
Intarcia Therapeutics, Inc. |
Implant placement guide
|
US10549081B2
(en)
|
2016-06-23 |
2020-02-04 |
Warsaw Orthopedic, Inc. |
Drug delivery device and methods having a retaining member
|
CN106074361B
(zh)
*
|
2016-07-14 |
2018-10-19 |
何伟 |
一种抗眼内炎症植入剂及其制备方法和应用
|
US10434261B2
(en)
|
2016-11-08 |
2019-10-08 |
Warsaw Orthopedic, Inc. |
Drug pellet delivery system and method
|
KR20190104039A
(ko)
|
2017-01-03 |
2019-09-05 |
인타르시아 세라퓨틱스 인코포레이티드 |
Glp-1 수용체 효능제의 연속적인 투여 및 약물의 동시-투여를 포함하는 방법
|
US10646484B2
(en)
|
2017-06-16 |
2020-05-12 |
Indivior Uk Limited |
Methods to treat opioid use disorder
|
CA3167217A1
(en)
|
2020-01-13 |
2021-07-22 |
Durect Corporation |
Sustained release drug delivery systems with reduced impurities and related methods
|
EP4173626A1
(en)
|
2021-10-29 |
2023-05-03 |
Charité - Universitätsmedizin Berlin |
Pentagalloyl glucose (pgg) for use in treatment of pulmonary hypertension
|
EP4218772A1
(en)
|
2022-01-26 |
2023-08-02 |
Charité - Universitätsmedizin Berlin |
Lithium salt for use in treatment of pulmonary hypertension
|